share_log

Expert Outlook: Tango Therapeutics Through The Eyes Of 6 Analysts

Expert Outlook: Tango Therapeutics Through The Eyes Of 6 Analysts

专家展望:从6位分析师的角度看Tango Therapeutics
Benzinga ·  07/09 09:00
In the preceding three months, 6 analysts have released ratings for Tango Therapeutics (NASDAQ:TNGX), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中,有6位分析师公布了Tango Therapeutics(纳斯达克股票代码:TNGX)的评级,提出了从看涨到看跌的各种观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级,展示了过去30天内不断变化的情绪,并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $13.5, a high estimate of $17.00, and a low estimate of $11.00. A 17.33% drop is evident in the current average compared to the previous average price target of $16.33.
分析师分析的12个月目标股价提供了见解,平均目标价为13.5美元,最高估计为17.00美元,低估值为11.00美元。与之前的平均目标股价16.33美元相比,当前的平均价格下降了17.33%。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级:仔细观察
An in-depth analysis of recent analyst actions unveils...
对分析师近期行为的...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发